Reecha Sofat
About
Reecha Sofat is a scholar working on Cardiology and Cardiovascular Medicine, Pediatrics, Perinatology and Child Health and Economics and Econometrics.
According to data from OpenAlex, Reecha Sofat has authored 71 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cardiology and Cardiovascular Medicine, 12 papers in Pediatrics, Perinatology and Child Health and 11 papers in Economics and Econometrics. Recurrent topics in Reecha Sofat's work include Health Systems, Economic Evaluations, Quality of Life (10 papers), Atrial Fibrillation Management and Outcomes (8 papers) and Genetic Associations and Epidemiology (7 papers). Reecha Sofat is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (10 papers), Atrial Fibrillation Management and Outcomes (8 papers) and Genetic Associations and Epidemiology (7 papers). Reecha Sofat collaborates with scholars based in United Kingdom, United States and Spain. Reecha Sofat's co-authors include Aroon D. Hingorani, Juan P. Casas, Philippa Davies, Julian P. T. Higgins, Diane Eaton, Nicky J. Welton, George N. Okoli, Howard Thom, Peter Bryden and Jonathan A C Sterne and has published in prestigious journals such as The Lancet, Circulation and Nature Medicine.
In The Last Decade
Reecha Sofat
69 papers receiving 2.3k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Reecha Sofat United Kingdom | 23 | 835 | 399 | 300 | 294 | 248 | 71 | 2.3k | ||
| Jan Westerink Netherlands | 27 | 966 1.2× | 497 1.2× | 277 0.9× | 131 0.4× | 766 3.1× | 131 | 2.7k | ||
| François Laliberté United States | 28 | 1.2k 1.4× | 208 0.5× | 191 0.6× | 132 0.4× | 253 1.0× | 208 | 2.8k | ||
| Susan Colilla United States | 17 | 1.0k 1.3× | 492 1.2× | 306 1.0× | 218 0.7× | 359 1.4× | 30 | 2.4k | ||
| Paul N. Jensen United States | 24 | 1.3k 1.5× | 296 0.7× | 540 1.8× | 104 0.4× | 297 1.2× | 48 | 2.4k | ||
| Tina Shah United States | 27 | 1.2k 1.4× | 622 1.6× | 530 1.8× | 413 1.4× | 624 2.5× | 70 | 3.3k | ||
| Sarah Parish United Kingdom | 33 | 1.2k 1.4× | 462 1.2× | 528 1.8× | 441 1.5× | 1.4k 5.4× | 84 | 3.9k | ||
| Scott M. Damrauer United States | 28 | 574 0.7× | 444 1.1× | 613 2.0× | 719 2.4× | 718 2.9× | 144 | 3.1k | ||
| Valeria Raparelli Italy | 32 | 1.2k 1.5× | 748 1.9× | 200 0.7× | 68 0.2× | 385 1.6× | 136 | 3.1k | ||
| James S. Floyd United States | 25 | 639 0.8× | 243 0.6× | 216 0.7× | 115 0.4× | 261 1.1× | 81 | 1.9k | ||
| Hester M. den Ruijter Netherlands | 39 | 2.5k 3.0× | 575 1.4× | 711 2.4× | 219 0.7× | 802 3.2× | 241 | 5.0k |
Countries citing papers authored by Reecha Sofat
Since
Specialization
Citations
This map shows the geographic impact of Reecha Sofat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reecha Sofat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reecha Sofat more than expected).
Fields of papers citing papers by Reecha Sofat
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Reecha Sofat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reecha Sofat. The network helps show where Reecha Sofat may publish in the future.
Co-authorship network of co-authors of Reecha Sofat
This figure shows the co-authorship network connecting the top 25 collaborators of Reecha Sofat. A scholar is included among the top collaborators of Reecha Sofat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reecha Sofat. Reecha Sofat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Sheikh, Jameela, John Allotey, Soha Sobhy, et al.. (2025). Maternal paracetamol (acetaminophen) use during pregnancy and risk of autism spectrum disorder and attention deficit/hyperactivity disorder in offspring: umbrella review of systematic reviews. BMJ. 391. e088141–e088141.
2.
Asiimwe, Innocent G., L. Walker, Reecha Sofat, Andrea Jorgensen, & Munir Pirmohamed. (2024). Genetic Determinants of Thiazide‐Induced Hyperuricemia, Hyperglycemia, and Urinary Electrolyte Disturbances – A Genome‐Wide Evaluation of the UK Biobank. Clinical Pharmacology & Therapeutics. 115(6). 1408–1417.
3.
Dal‐Ré, Rafael, Arthur L. Caplan, Søren Holm, Reecha Sofat, & Richard Stephens. (2024). Adequate information about clinical trial results must be given to participants. Nature Medicine. 30(9). 2404–2406.
4.
Schnier, Christian, Daniel R. Morales, Ashley Akbari, et al.. (2023). Antipsychotic drug prescribing and mortality in people with dementia before and during the COVID-19 pandemic: a retrospective cohort study in Wales, UK. The Lancet Healthy Longevity. 4(8). e421–e430.
5.
Gratton, Jasmine, Steve E. Humphries, Amand F. Schmidt, et al.. (2023). Modelling a two-stage adult population screen for autosomal dominant familial hypercholesterolaemia: cross-sectional analysis within the UK Biobank. SHILAP Revista de lepidopterología. 1(1). e000021–e000021.
6.
Chung, Jennifer, et al.. (2023). Effectiveness of biosimilar adoption within a UK tertiary hospital: 6‐year follow‐up. British Journal of Clinical Pharmacology. 89(10). 2944–2949.
7.
Olvera‐Barrios, Abraham, Alicja R. Rudnicka, John Anderson, et al.. (2023). Two-year recall for people with no diabetic retinopathy: a multi-ethnic population-based retrospective cohort study using real-world data to quantify the effect. British Journal of Ophthalmology. 107(12). 1839–1845.
8.
Hingorani, Aroon D., Jasmine Gratton, Chris Finan, et al.. (2023). Performance of polygenic risk scores in screening, prediction, and risk stratification: secondary analysis of data in the Polygenic Score Catalog. SHILAP Revista de lepidopterología. 2(1). e000554–e000554.
9.
Ferner, R E, et al.. (2023). How to assess pharmacogenomic tests for implementation in the NHS in England. British Journal of Clinical Pharmacology. 89(9). 2649–2657.
10.
Handy, Álex, Amitava Banerjee, Angela Wood, et al.. (2022). Evaluation of antithrombotic use and COVID-19 outcomes in a nationwide atrial fibrillation cohort. Heart. 108(12). 923–931.
11.
Ferner, R E, et al.. (2021). Free‐of‐charge medicine schemes in the NHS: A local and regional drug and therapeutic committee's experience. British Journal of Clinical Pharmacology. 88(6). 2571–2580.
12.
Bennett, Frances & Reecha Sofat. (2020). Polypharmacy: the whys, the so whats and the what nexts. British Journal of Hospital Medicine. 81(5). 1–7.
13.
Bodalia, Pritesh, et al.. (2019). A novel approach to support implementation of biosimilars within a UK tertiary hospital. British Journal of Clinical Pharmacology. 86(1). 23–28.
14.
Pasea, Laura, Sheng‐Chia Chung, Mar Pujades‐Rodríguez, et al.. (2019). Bleeding in cardiac patients prescribed antithrombotic drugs: electronic health record phenotyping algorithms, incidence, trends and prognosis. BMC Medicine. 17(1). 206–206.
15.
Thom, Howard, William Hollingworth, Jonathan A C Sterne, et al.. (2015). The Cost-Effectiveness Of Novel Oral Anticoagulants For The Prevention Of Stroke In Atrial Fibrillation In England And Wales. Value in Health. 18(7). A391–A392.
16.
López-López, José A, Jonathan A C Sterne, Philippa Davies, et al.. (2015). Network Meta-Analysis of Oral Anticoagulants for Primary Prevention, Treatment and Secondary Prevention of Venous Thromboembolic Disease, and for Prevention of Stroke in Atrial Fibrillation. Value in Health. 18(7). A374–A374.
17.
Bryden, Peter, Nicky J. Welton, Howard Thom, et al.. (2015). A Cost-Effectiveness Analysis Of Novel Oral Anticoagulants For Acute Treatment And Secondary Prevention Of Venous Thromboembolic Disease. Value in Health. 18(7). A390–A390.
18.
Sofat, Reecha, J. P. Casas, B. N. C. Prichard, et al.. (2012). Could NICE guidance on the choice of blood pressure lowering drugs be simplified?. BMJ. 344(jan13 1). d8078–d8078.
19.
Sofat, Reecha, Juan P. Casas, Meena Kumari, et al.. (2010). Genetic variation in complement factor H and risk of coronary heart disease: Eight new studies and a meta-analysis of around 48,000 individuals. Atherosclerosis. 213(1). 184–190.
20.
Holmes, Michael V., Sonia Shah, Aspasia Angelakopoulou, et al.. (2009). Complex disease genetics: present and future translational applications. Genome Medicine. 1(11). 104–104.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Jan Westerink Breakdown of academic impact, for papers by François Laliberté Breakdown of academic impact, for papers by Susan Colilla Breakdown of academic impact, for papers by Paul N. Jensen Breakdown of academic impact, for papers by Tina Shah Breakdown of academic impact, for papers by Sarah Parish Breakdown of academic impact, for papers by Scott M. Damrauer Breakdown of academic impact, for papers by Valeria Raparelli Breakdown of academic impact, for papers by James S. Floyd Breakdown of academic impact, for papers by Hester M. den Ruijter